"Futurable energy." This is the goal of Newcleo, a start-up founded by Stefano Buono with an initial capital of more than 100 million euros and aiming to engage up to 900 engineers and technicians between Italy, France and the UK by 2030.
After years of experience in biotech with the company AAA, acquired in 2018 by Novartis for $3.9 billion, the physicist and entrepreneur decided to build on Italian and Piedmontese know-how in the nuclear field to expand onto global markets.
Newcleo aspires to reinvent nuclear power by "developing a new way to control the process of extracting energy from cores that is sustainable and completely safe." An innovation that will enable the planet to achieve zero emissions and significantly reduce global warming.
The Ambrosetti Club meeting will be the perfect chance for a direct and informal discussion with Stefano Buono, CEO of Newcleo, who will share with us his ideas and plans to revolutionize the nuclear energy sector, delving into its implications for citizens and businesses.